LucyDx

LucyDx is a medical technology company building the next generation diagnostic headset for the early detection of diabetic retinopathy. We are helping to prevent blindness through early detection and tracking of your eye health.

Print
Follow Claim My Business
Security Type
Common Stock
Categories
Healthcare & Medical, Technology
Min Investment
$104
Location
Newark, DE
Offering Date
March 29, 2023
Expected Close Date
April 30, 2025
Target Raise
$10.00K-$608.00K
Security Price
$8
Valuation
$8,000,000
Website
lucydx.co
Number of Employees
0
Cash
$9,031
Revenue
$0
Short Term Debt
$0
Cost of Goods
$0
Long Term Debt
$0
Net Income
$-15,878

Company Description

LucyDx is an early-stage medical technology company launched in February 2021 out of the FedTech Startup Studio Fall 2020 cohort with the purpose of commercializing a wearable diagnostic device for the early detection of diabetic retinopathy. Our team was carefully evaluated on several verticals and selected by FedTech with qualifications and expertise suitable for the commercialization of this particular technology based on our extensive experience in medical devices, diagnostics, hardware, software, firmware, and wearables. We have pinpointed a target market and validated demand through dozens of customer discovery interviews with various physicians, health care providers, educators, and diabetics making us a primarily a direct to consumer business. We have confirmed that our proposed application of the technology has an existing reimbursement (CPT) code and plans to be Medicare-eligible; hence, it can be reimbursable through many private health insurance plans. This technology is being licensed from governmental and educational institutions.We are driven by our success in the Mass Challenge 2021 program as Gold Award winners. 

Amount Raised : $12,192
Reveal the Score by Voting
_
0
Business Idea
Business Traction
Management Team
Valuation

Security Description

Common stock is a security that represents ownership in a corporation.

Research Reports

No reports have been submitted

Become a Reporter

0 Comments